Ca22 Benzoyl Peroxide Cleansing
NDC 82575-122
Product Information
Ca22 Benzoyl Peroxide Cleansing is a OTC MONOGRAPH FINAL-approved product labeled by Curology Inc.. This product is primarily utilized in pharmaceutical processing or compounding. It is supplied as a product. This product entry covers the primary NDC 82575-122 and 3 associated package configurations. This profile includes active and inactive ingredient UNII references and FDA labeling data.
Primary Identification
Labeler & Regulatory Data
Marketing Timeline
Code Structure Chart
Product Details
What is NDC 82575-122?
What are the uses of this product?
Which are the associated UNII Codes?
The UNII codes for the active ingredients in this product are:
- BENZOYL PEROXIDE (UNII: W9WZN9A0GM)
- BENZOYL PEROXIDE (UNII: W9WZN9A0GM) (Active Moiety)
Which are the Inactive Ingredients associated UNII Codes?
The inactive ingredients are all the component of a medicinal product OTHER than the active ingredient(s). The acronym "UNII" stands for “Unique Ingredient Identifier” and is used to identify each inactive ingredient present in a product. The UNII codes for the inactive ingredients in this product are:
- WATER (UNII: 059QF0KO0R)
- SODIUM C12-14 OLEFIN SULFONATE (UNII: 7I962MCQ71)
- GLYCERIN (UNII: PDC6A3C0OX)
- PROPYLENE GLYCOL (UNII: 6DC9Q167V3)
- DISODIUM COCOAMPHODIACETATE (UNII: 18L9G3U51M)
- CARBOMER HOMOPOLYMER, UNSPECIFIED TYPE (UNII: 0A5MM307FC)
- HYALURONATE SODIUM (UNII: YSE9PPT4TH)
- SODIUM HYDROXIDE (UNII: 55X04QC32I)
- PHENOXYETHANOL (UNII: HIE492ZZ3T)
- EDETATE DISODIUM ANHYDROUS (UNII: 8NLQ36F6MM)
- ALLANTOIN (UNII: 344S277G0Z)
- PANTHENOL (UNII: WV9CM0O67Z)
- ETHYLHEXYLGLYCERIN (UNII: 147D247K3P)
What is the NDC to RxNorm Crosswalk for this product?
- RxCUI: 845836 - benzoyl peroxide 2.5 % Medicated Liquid Soap
- RxCUI: 845836 - benzoyl peroxide 25 MG/ML Medicated Liquid Soap
* Please review the full disclaimer at the bottom of this page.
Patient Education
Benzoyl Peroxide Topical
Benzoyl peroxide is used to treat mild to moderate acne.
[Learn More]
* Please review the full disclaimer at the bottom of this page.